Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492745.RAWK0RYAyUmCSd4fqyg37gx-Xr7sEwNGgSxw58nde6s9o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492745.RAWK0RYAyUmCSd4fqyg37gx-Xr7sEwNGgSxw58nde6s9o130_assertion type Assertion NP492745.RAWK0RYAyUmCSd4fqyg37gx-Xr7sEwNGgSxw58nde6s9o130_head.
- NP492745.RAWK0RYAyUmCSd4fqyg37gx-Xr7sEwNGgSxw58nde6s9o130_assertion description "[We have shown that treatment with interleukin-2 (IL-2) or interferon-alpha (IFN alpha) may induce depressive symptoms and activation of the cytokine network and that IL-2 treatment may diminish serum dipeptidyl pepdidase IV (DPP IV) activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492745.RAWK0RYAyUmCSd4fqyg37gx-Xr7sEwNGgSxw58nde6s9o130_provenance.
- NP492745.RAWK0RYAyUmCSd4fqyg37gx-Xr7sEwNGgSxw58nde6s9o130_assertion evidence source_evidence_literature NP492745.RAWK0RYAyUmCSd4fqyg37gx-Xr7sEwNGgSxw58nde6s9o130_provenance.
- NP492745.RAWK0RYAyUmCSd4fqyg37gx-Xr7sEwNGgSxw58nde6s9o130_assertion SIO_000772 11443537 NP492745.RAWK0RYAyUmCSd4fqyg37gx-Xr7sEwNGgSxw58nde6s9o130_provenance.
- NP492745.RAWK0RYAyUmCSd4fqyg37gx-Xr7sEwNGgSxw58nde6s9o130_assertion wasDerivedFrom befree-20150227 NP492745.RAWK0RYAyUmCSd4fqyg37gx-Xr7sEwNGgSxw58nde6s9o130_provenance.
- NP492745.RAWK0RYAyUmCSd4fqyg37gx-Xr7sEwNGgSxw58nde6s9o130_assertion wasGeneratedBy ECO_0000203 NP492745.RAWK0RYAyUmCSd4fqyg37gx-Xr7sEwNGgSxw58nde6s9o130_provenance.